News

Azlocillin can be the potential drug candidate against drug-tolerant Borrelia burgdorferi sensu stricto JLB31

Flightpath participates in the “New Commitment to Patients” to Ensure Access and Act with Integrity and Responsibility

Chronic Lyme Disease: An Evidence Based Definition

PUBLICATIONS

March 2, 2020

Azlocillin can be the potential drug candidate against drug-tolerant Borrelia burgdorferi sensu stricto JLB31

Venkata Raveendra Pothineni, Hari-Hara S. K. Potula, Aditya Ambati,
Venkata Vamsee Aditya Mallajosyula, Brindha Sridharan, Mohammed Inayathullah, Mohamed Sohail Ahmed, and Jayakumar Rajadas

VIEW PDF

May 30, 2019

Disulfiram (Tetraethylthiuram Disulfide) in the Treatment of Lyme Disease and Babesiosis: Report of Experience in Three Cases

By Kenneth Liegner

VIEW PDF

December 16, 2019

Chronic Lyme Disease: An Evidence-Based Definition by the ILADS Working Group

By Samuel Shor, Christine Green, Beatrice Szantyr, Steven Philips, Kenneth Liegner, Joseph Burrascano Jr., Robert Bransfield, Elizabeth L. Maloney

VIEW PDF

NEW
03-31-2020

Conference/WG Meeting Clips/Neuropsychiatric Lyme/COVID-19/House Lyme Caucus/Monies for Researchers/WG Meeting Summary/Tickmojis

NEW
03-31-2020

TBDWG Mtg 12: S. Donta, MD: Lyme / Other Clips (Video)

NEW
03-30-2020

ClinicalTrials.gov

NEW
03-30-2020

TBDWG Mtg 12: Public Comments (Video)

NEW
03-30-2020

12th meeting of the TBDWG-Summary

NEW
03-29-2020

Tickmojis: Get Yours Free Today!

We would like to collect information during your visit to help us better understand site use. This data is anonymized, and will not be used for marketing purposes. Read More on our Privacy Policy page. You can withdraw permission at any time or update your privacy settings here. Please choose below to continue.